OrthoPediatrics Sees FY23 Revenue $148M-$152M Vs $149.17M Est.
Portfolio Pulse from Benzinga Newsdesk
OrthoPediatrics has reiterated its revenue guidance for FY23 to be in the range of $148.0 million to $151.0 million, representing a growth of 21% to 23% over 2022 revenue. The company also expects annual set deployments of approximately $23.0 million and $4.0 million to $5.0 million of adjusted EBITDA for the full year of 2023.
November 06, 2023 | 9:26 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OrthoPediatrics' FY23 revenue guidance aligns with estimates, indicating a strong growth trajectory. This could potentially boost investor confidence in the company.
OrthoPediatrics' FY23 revenue guidance is in line with estimates, which indicates a strong growth trajectory. This could potentially boost investor confidence in the company, leading to a positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100